Molecular characterization and typing of enrofloxacin-resistant clinical isolates of Mycoplasma gallisepticum

Avian Diseases

Volumn 52, Issue 4, 2008, Pages 685-689

  Lysnyansky, I ^a   Gerchman, I ^a   Perk, S ^a   Levisohn, S ^a  

^a KIMRON VETERINARY INSTITUTE   (Israel)

Author keywords

Enrofloxacin; Molecular typing; Mycoplasma gallisepticum; Quinolone resistance determining regions; Resistance

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; ENROFLOXACIN; QUINOLONE DERIVATIVE;

AMINO ACID SUBSTITUTION; ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; CHEMISTRY; CHICKEN; CLASSIFICATION; DRUG EFFECT; GENETICS; MOLECULAR GENETICS; MUTATION; MYCOPLASMA GALLISEPTICUM; NUCLEOTIDE SEQUENCE; RANDOM AMPLIFIED POLYMORPHIC DNA; TURKEY (BIRD);

AMINO ACID SUBSTITUTION; ANIMALS; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CHICKENS; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GENES, BACTERIAL; MOLECULAR SEQUENCE DATA; MUTATION; MYCOPLASMA GALLISEPTICUM; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TURKEYS;

MYCOPLASMA GALLISEPTICUM;

EID: 58149091908     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/8386-063008-RESNOTE.1     Document Type: Article

References (20)

1. Bebear, C. M., and C. Bebear. Antimycoplasmal agents. In: Molecular biology and pathogenicity of mycoplasmas. S. Razin, and R. Herrmann, eds. Plenum Publishers, New York. pp. 545-566. 2002.
2. Bebear, C. M., H. Renaudin, A. Charron, M. Clerc, S. Pereyre, and C. Bebear. DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones. Antimicrob. Agents Chemother. 47:3323-3325. 2003.
3. Bebear, C. M., H. Renaudin, A. Charron, D. Gruson, M. Lefrancois, and C. Bebear. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob. Agents Chemother. 44:2557-2560. 2000.
4. Buyuktanyr, O., T. Yyldyrym, C. Yakycyer, O. Genc, and N. Yurdusev. A recombinant PvpA protein-based diagnostic prototype for rapid screening of chicken Mycoplasma gallisepticum infections. Vet. Microbiol. 129:139-149. 2007.
5. Fan, H. H., S. H. Kleven, and M. W. Jackwood. Application of polymerase chain reaction with arbitrary primers to strain identification of Mycoplasma gallisepticum. Avian Dis. 39:729-735. 1995.
6. Ferguson, N. M., D. Hepp, S. Sun, N. Ikuta, S. Levisohn, S. H. Kleven, and M. Garcia. Use of molecular diversity of Mycoplasma gallisepticum by gene-targeted sequencing (GTS) and random amplified polymorphic DNA (RAPD) analysis for epidemiological studies. Microbiology 151:1883-1893. 2005.
7. Geary, S. J., M. H. Forsyth, S. A. Saoud, G. Wang, D. E. Berg, and C. M. Berg. Mycoplasma gallisepticum strain differentiation by arbitrary primer PCR (RAPD) fingerprinting. Mol. Cell. Probes 8:311-316. 1994.
8. Gerchman, I., I. Lysnyansky, S. Perk, and S. Levisohn. In vitro susceptibilities to fluoroquinolones in current and archived Mycoplasma gallisepticum and Mycoplasma synoviae isolates from meat-type turkeys. Vet. Microbiol. 131:266-276. 2008.
9. Hannan, P. C. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. Vet. Res. 31:373-395. 2000.
10. Hirose, K., Y. Kawasaki, K. Kotani, K. Abiko, and H. Sato. Characterization of a point mutation in the parC gene of Mycoplasma bovirhinis associated with fluoroquinolone resistance. J. Vet. Med. B 51:169-175. 2004.
11. Hong, Y., M. Garcia, S. Levisohn, I. Lysnyansky, V. Leiting, P. H. M. Savelkoul, and S. H. Kleven. Evaluation of amplified fragment length polymorphism for differentiation of avian mycoplasma species. J. Clin. Microbiol. 43:909-912. 2005.
12. Hooper, D. C. Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance. Clin. Infect. Dis. 27:S54-S63. 1998.
13. Kleven, S. H., and S. Levisohn. Mycoplasma infections of poultry. In: Molecular and diagnostic procedures in mycoplasmology, vol. II, 1st ed. J. G. Tully, and S. Razin, eds. Academic Press, New York. pp. 283-292. 1996.
14. Ley, D. H., J. E. Berkhoff, and S. Levisohn. Molecular epidemiological investigations of Mycoplasma gallisepticum (MG) conjunctivitis in songbirds by random amplified polymorphic DNA (RAPD) analyses. Emerg. Infect. Dis. 3:375-380. 1997.
15. Morgan-Linnell, S. K., and L. Zechiedrich. Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 51: 4205-4208. 2007.
16. National Committee for Clinical Laboratory Standards (NCCLS). Development of in vitro susceptibility testing criteria and quality control parameters for veterinary antimicrobial agents. Approved guideline 22. 2002. National Committee for Clinical Laboratory Standards, Villanova, PA.
17. Pakpinyo, S., and J. Sasipreeyajan. Molecular characterization and determination of antimicrobial resistance of Mycoplasma gallisepticum isolated from chickens. Vet. Microbiol. 125:59-65. 2007.
18. Papazisi, L., T. S. Gorton, G. Kutish, P. F. Markham, G. F. Browning, D. K. Nguyen, S. Swartzell, A. Madan, G. Mahairas, and S. J. Geary. The complete genome sequence of the avian pathogen Mycoplasma gallisepticum strain R(low). Microbiology 149:2307-2316. 2003.
19. Reinhardt, A. K., C. M. Bebear, M. Kobisch, I. Kempf, and A. V. Gautier-Bouchardon. Characterization of mutations in DNA gyrase and topoisomerase IV involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro. Antimicrob. Agents Chemother. 46:590-593. 2002.
20. Reinhardt, A. K., I. Kempf, M. Kobisch, and A. V. Gautier-Bouchardon. Fluoroquinolone resistance in Mycoplasma gallisepticum: DNA gyrase as primary target of enrofloxacin and impact of mutations in topoisomerases on resistance level. J. Antimicrob. Chemother. 50:589-592. 2002.